Rare Disease Report
Patients & Caregivers

Is Carfilzomib Safe for AL Amyloidosis Patients?

DECEMBER 27, 2016
Brendan Weiss, MD

Brendan Weiss, MD of the University of Pennsylvania summarizes a study presented that the 2016 ASH Meeting that examined the safety and efficacy of carfilzomib to treat patients with AL amyloidosis.


Cohen AD, Landau H, Scott EC, et al. Safety and Efficacy of Carfilzomib (CFZ) in Previously-Treated Systemic Light-Chain (AL) Amyloidosis. Presented at 58th Annual ASH Meeting & Exposition; San Diego, CA; December 3-6, 2016, Abstract 645.

Copyright © RareDR 2013-2017 Rare Disease Communications. All Rights Reserved.